Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. A new era in CAR-NK cell therapy: from technological innovations to clinical applications.World journal of pediatrics : WJP · 2026
   Review
2. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.Cells · 2024
   Review
3. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.Asian Pacific journal of cancer prevention : APJCP · 2020
   Article
4. Phase I study of cellular therapy usingHaematologica · 2020
   Article
5. Challenges of NK cell-based immunotherapy in the new era.Frontiers of medicine · 2018
   Review
6. Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.Frontiers in immunology · 2017
   Review
7. Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.Oncoimmunology · 2016
   Article
8. Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.Bone marrow transplantation · 2016
   Review
9. Combined IL-15 and IL-12 drives the generation of CD34Oncoimmunology · 2015
   Article
10. Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Frontiers in immunology · 2015
    Review
11. Improving engraftment and immune reconstitution in umbilical cord blood transplantation.Frontiers in immunology · 2014
    Review
12. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.PloS one · 2013
    Article
13. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.Cellular & molecular immunology · 2012
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as